Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
about
Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritisA pilot study of leukocyte expression patterns for drug metabolizing enzyme and transporter transcripts in autoimmune glomerulonephritis.Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.Mycophenolic acid differentially impacts B cell function depending on the stage of differentiation.Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseasesInfluence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis.In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases.Impact of glomerular kidney diseases on the clearance of drugs.Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease.Pharmacokinetic modeling of therapies for systemic lupus erythematosus.Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil.Effective plasma concentrations of mycophenolic acid and its glucuronide in systemic lupus erythematosus patients in the remission-maintenance phase.Glucuronidation: driving factors and their impact on glucuronide disposition
P2860
Q28285877-0BB61B36-DB97-414B-A701-119DACECBEC2Q34010773-DBFC3C52-8182-4C93-83AD-BDBE249B7A7EQ34152549-39A0AA14-D04B-4D1C-B7C4-B914754BCD35Q34267100-2AD9554E-7CC9-40CF-83AB-0FDE24FC90B0Q36733922-4D06BFBB-529B-405E-9C30-FA696544AC77Q37423423-6AF8D082-BB3A-4F82-BB2B-AEB85F4F253EQ37622756-146AF11A-E5DF-4382-9B1A-4B2C45E930B2Q37974647-C39147F1-13FC-4F9E-BC8D-52114CA68065Q38087925-3605898F-91BF-4B5A-BA47-A8D5BC474DDCQ38542910-2BFFA408-1A1D-440F-B60F-10DDDE0B205FQ45353017-B2B4BBDE-CAE7-474B-B8EA-E8C1DFA66960Q50539103-35C69814-201C-499B-8E7F-424EF85FCC46Q56030213-03205BE0-3FFD-4486-9CBE-E65C2BA99491
P2860
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
@ast
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
@en
type
label
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
@ast
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
@en
prefLabel
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
@ast
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
@en
P2093
P2860
P356
P1433
P1476
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.
@en
P2093
Mary Anne Dooley
Melanie S Joy
Philip C Smith
Ronald J Falk
Susan L Hogan
Tandrea Hilliard
P2860
P356
10.1592/PHCO.29.1.7
P407
P577
2009-01-01T00:00:00Z